AG
EVH icon

Advisor Group’s Evolent Health EVH Stock Holding History

Advisor Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$79K Sell
8,730
-1,448
-14% -$11.8K ﹤0.01% 3098
2019
Q3 		$74K Sell
10,178
-3,390
-25% -$24.3K ﹤0.01% 3110
2019
Q2 		$108K Sell
13,568
-5,504
-29% -$65.2K ﹤0.01% 2795
2019
Q1 		$240K Buy
19,072
+2,044
+12% +$32.4K ﹤0.01% 2131
2018
Q4 		$339K Sell
17,028
-13,131
-44% -$304K ﹤0.01% 1684
2018
Q3 		$856K Buy
30,159
+7,606
+34% +$181K 0.01% 1099
2018
Q2 		$474K Buy
22,553
+1,206
+6% +$22.8K 0.01% 1344
2018
Q1 		$304K Buy
21,347
+15,918
+293% +$228K ﹤0.01% 1681
2017
Q4 		$67K Buy
5,429
+1,199
+28% +$16.9K ﹤0.01% 2872
2017
Q3 		$75K Buy
4,230
+712
+20% +$14.7K ﹤0.01% 2643
2017
Q2 		$89K Buy
3,518
+3,318
+1,659% +$79.8K ﹤0.01% 2399
2017
Q1 		$4K Sell
200
-100
-33% -$1.92K ﹤0.01% 4192
2016
Q4 		$4K Buy
+300
New +$5.91K ﹤0.01% 4009

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Advisor Group's EVH Position: Q4 2019 in Review

Advisor Group reduced its Evolent Health (EVH) stake by 14% in Q4 2019, selling an estimated $11.8K and leaving 8,730 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #3098.

Advisor Group first reported a position in EVH in Q4 2016 and has held it in 13 quarters since. The position peaked at $856K in Q3 2018. 167 funds tracked by Wall St. Rank hold EVH as of Q4 2019.

  • Advisor Group held 8,730 shares of Evolent Health worth $79K as of Q4 2019.
  • Advisor Group sold 1,448 Evolent Health shares in Q4 2019, an estimated $11.8K.
  • Evolent Health made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3098 holding.
  • Advisor Group first reported a position in Evolent Health in Q4 2016 and has held it in 13 quarters since.
  • Advisor Group's Evolent Health position peaked at $856K in Q3 2018.
  • 167 funds tracked by Wall St. Rank held Evolent Health as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.